drugset / Trial / NCT06658626

A Study to Evaluate the Metabolism, Excretion, and Mass Balance of [¹⁴C]Enlicitide Chloride ([¹⁴C]MK-0616) in Healthy Participants (MK-0616-016)

NCT06658626

Phase 1 Completed 8 enrolled Merck Sharp & Dohme LLC
NaSingle-groupOpen-labelBasic science

Summary

The purpose of this study is to learn what happens to enlicitide chloride labeled with \[¹⁴C\] in a person's body over time. A label can be added to a study medicine to trace it in a person's body.

Timeline

Start
2023-03-10
Primary completion
2023-08-02
Completion
2023-08-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Enlicitide Unknown Intravenous

Indications

No indication recorded.